MLGA: a cost-effective approach to the diagnosis of gene deletions in eye development anomalies

por Wyatt, Alexander W., Ragge, Nicola
Publicado 2009

Targeting the adaptive molecular landscape of castration-resistant prostate cancer

por Wyatt, Alexander W, Gleave, Martin E
Publicado en EMBO Mol Med (2015)

The diverse heterogeneity of molecular alterations in prostate cancer identified through next-generation sequencing

por Wyatt, Alexander W, Mo, Fan, Wang, Yuzhuo, Collins, Colin C
Publicado 2013

Biomarkers for Programmed Death‐1 Inhibition in Prostate Cancer

por Manogue, Charlotte, Cotogno, Patrick, Ledet, Elisa, Lewis, Brian, Wyatt, Alexander W., Sartor, Oliver
Publicado en Oncologist (2018)

nFuse: Discovery of complex genomic rearrangements in cancer using high-throughput sequencing

por McPherson, Andrew, Wu, Chunxiao, Wyatt, Alexander W., Shah, Sohrab, Collins, Colin, Sahinalp, S. Cenk
Publicado 2012

Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors

por Lavoie, Jean-Michel, Vandekerkhove, Gillian, Murtha, Andrew J., Wang, Gang, Wyatt, Alexander W., Eigl, Bernhard J.
Publicado en Urol Case Rep (2021)

A Meta-Analysis Approach for Characterizing Pan-Cancer Mechanisms of Drug Sensitivity in Cell Lines

por Wang, Kendric, Shrestha, Raunak, Wyatt, Alexander W., Reddy, Anupama, Lehár, Joseph, Wang, Yuzhou, Lapuk, Anna, Collins, Colin C.
Publicado 2014

Frequent mutation of the FOXA1 untranslated region in prostate cancer

por Annala, Matti, Taavitsainen, Sinja, Vandekerkhove, Gillian, Bacon, Jack V. W., Beja, Kevin, Chi, Kim N., Nykter, Matti, Wyatt, Alexander W.
Publicado en Commun Biol (2018)

Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer

por Tesch, Megan E., Pater, Justin A., Vandekerkhove, Gillian, Wang, Gang, Binnington, Kristin, So, Alan I., Wyatt, Alexander W., Eigl, Bernhard J.
Publicado en NPJ Genom Med (2020)

Next-Generation Sequencing of Prostate Tumors Provides Independent Evidence of Xenotropic Murine Leukemia Virus-Related Gammaretrovirus Contamination

por Mo, Fan, Wyatt, Alexander W., Wu, Chunxiao, Lapuk, Anna V., Marra, Marco A., Gleave, Martin E., Volik, Stanislav V., Collins, Colin C.
Publicado 2012

Evaluation of Commercial Circulating Tumor DNA Test in Metastatic Prostate Cancer

por Taavitsainen, Sinja, Annala, Matti, Ledet, Elisa, Beja, Kevin, Miller, Patrick J., Moses, Marcus, Nykter, Matti, Chi, Kim N., Sartor, Oliver, Wyatt, Alexander W.
Publicado en JCO Precis Oncol (2019)

Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

por Gonzalez, David, Mateo, Joaquin, Stenzinger, Albrecht, Rojo, Federico, Shiller, Michelle, Wyatt, Alexander W, Penault‐Llorca, Frédérique, Gomella, Leonard G, Eeles, Ros, Bjartell, Anders
Publicado en J Pathol Clin Res (2021)

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

por Lowes, Lori E., Bratman, Scott V., Dittamore, Ryan, Done, Susan, Kelley, Shana O., Mai, Sabine, Morin, Ryan D., Wyatt, Alexander W., Allan, Alison L.
Publicado en Int J Mol Sci (2016)

Next generation patient-derived prostate cancer xenograft models

por Lin, Dong, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Watahiki, Akira, Dong, Xin, Cheng, Hongwei, Wyatt, Alexander W, Collins, Colin C, Gout, Peter W, Wang, Yuzhuo
Publicado 2014

Systematic Identification and Characterization of RNA Editing in Prostate Tumors

por Mo, Fan, Wyatt, Alexander W., Sun, Yue, Brahmbhatt, Sonal, McConeghy, Brian J., Wu, Chunxiao, Wang, Yuzhuo, Gleave, Martin E., Volik, Stanislav V., Collins, Colin C.
Publicado 2014

Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR

por Alcaide, Miguel, Cheung, Matthew, Hillman, Jack, Rassekh, S. Rod, Deyell, Rebecca J., Batist, Gerald, Karsan, Aly, Wyatt, Alexander W., Johnson, Nathalie, Scott, David W., Morin, Ryan D.
Publicado en Sci Rep (2020)

Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33

por Saranchova, Iryna, Han, Jeffrey, Huang, Hui, Fenninger, Franz, Choi, Kyung Bok, Munro, Lonna, Pfeifer, Cheryl, Welch, Ian, Wyatt, Alexander W., Fazli, Ladan, Gleave, Martin E., Jefferies, Wilfred A.
Publicado en Sci Rep (2016)

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer

por Reimers, Melissa A., Yip, Steven M., Zhang, Li, Cieslik, Marcin, Dhawan, Mallika, Montgomery, Bruce, Wyatt, Alexander W., Chi, Kim N., Small, Eric J., Chinnaiyan, Arul M., Alva, Ajjai S., Feng, Felix Y., Chou, Jonathan
Publicado en Eur Urol (2019)

ShatterProof: operational detection and quantification of chromothripsis

por Govind, Shaylan K, Zia, Amin, Hennings-Yeomans, Pablo H, Watson, John D, Fraser, Michael, Anghel, Catalina, Wyatt, Alexander W, van der Kwast, Theodorus, Collins, Colin C, McPherson, John D, Bristow, Robert G, Boutros, Paul C
Publicado 2014

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies

por Jäger, Wolfgang, Xue, Hui, Hayashi, Tetsutaro, Janssen, Claudia, Awrey, Shannon, Wyatt, Alexander W., Anderson, Shawn, Moskalev, Igor, Haegert, Anne, Alshalalfa, Mohammed, Erho, Nicholas, Davicioni, Elai, Fazli, Ladan, Li, Estelle, Collins, Colin, Wang, Yuzhuo, Black, Peter C.
Publicado en Oncotarget (2015)